Related Experiment Video

Updated: Aug 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[Screening and diagnosis of hepatitis B and C]

Stéphane Chevaliez1, Jean-Michel Pawlotsky

  • 1Laboratoire de virologie, Inserm U635, hôpital Henri Mondor, Université Paris 12, 94010 Créteil Cedex.

La Revue Du Praticien
|May 26, 2005
PubMed

Insights

Virological diagnosis of viral hepatitis uses direct and indirect markers. Hepatitis B and C diagnoses rely on specific antigen, antibody, and genetic material detection for effective treatment monitoring.

Area of Science:

  • Virology
  • Immunology
  • Molecular Diagnostics

Context:

  • Viral hepatitis diagnosis relies on detecting viral components and host immune responses.
  • Hepatitis B and C are significant global health concerns requiring accurate diagnostic methods.

Purpose:

  • To outline the diagnostic strategies for viral hepatitis, focusing on Hepatitis B and C.
  • To describe the role of molecular techniques and marker interpretation in patient management.

Summary:

  • Virological diagnosis involves analyzing viral antigens, genomes (DNA/RNA), and specific antibodies.
  • Hepatitis B diagnosis uses antigen-antibody profiles and HBV DNA; treatment response is monitored via HBe seroconversion and HBV DNA levels.
  • Hepatitis C diagnosis requires anti-HCV antibody and HCV RNA detection, with genotyping guiding treatment and molecular assays confirming viral clearance.

Impact:

  • Accurate diagnosis and monitoring are crucial for effective hepatitis B and C treatment strategies.
  • Genotyping in Hepatitis C allows personalized treatment, improving outcomes.
  • Molecular diagnostics enable precise assessment of treatment efficacy, ensuring viral clearance.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...